Search

Your search keyword '"Lehmberg, K"' showing total 149 results

Search Constraints

Start Over You searched for: Author "Lehmberg, K" Remove constraint Author: "Lehmberg, K"
149 results on '"Lehmberg, K"'

Search Results

2. Global effort to evacuate Ukrainian children with cancer and blood disorders who have been affected by war

3. Allogeneic hematopoietic stem cell transplantation for adult HLH: a retrospective study by the chronic malignancies and inborn errors working parties of EBMT

4. Essential medicines for childhood cancer in Europe: a pan-European, systematic analysis by SIOPE

5. Targeted busulfan-based reduced-intensity conditioning and HLA-matched HSCT cure hemophagocytic lymphohistiocytosis

6. Simple Measurement of IgA Predicts Immunity and Mortality in Ataxia-Telangiectasia

10. Inflammasom-vermittelte monogene Erkrankungen mit Manifestation im Neugeborenenalter: 2 Fallberichte

12. Expert consensus on dynamics of laboratory tests for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis

13. Clinical features, treatment, and outcome of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a multinational, multicenter study of 362 patients

14. Mutations in EXTL3 Cause Neuro-immuno-skeletal Dysplasia Syndrome

15. The German PID-net registry

16. Expert consensus on dynamics of laboratory tests for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis

17. Development and initial validation of the macrophage activation syndrome/primary hemophagocytic lymphohistiocytosis score, a diagnostic tool that differentiates primary hemophagocytic lymphohistiocytosis from macrophage activation syndrome

18. X-linked inhibitor of apoptosis (XIAP) deficiency: The spectrum of presenting manifestations beyond hemophagocytic lymphohistiocytosis

20. SAT0486 Macrophage Activation Syndrome and Familial Hemophagocytic Lymphohistiocytosis: Is Their Clinical Phenotype Really Similar?

21. AP3D Deficiency Defines a New Type of Hermansky-Pudlak Syndrome

22. X-linked inhibitor of apoptosis (XIAP) deficiency:The spectrum of presenting manifestations beyond hemophagocytic lymphohistiocytosis

23. Structure of human Munc18-2

26. Sequential decisions on FAS sequencing guided by biomarkers in patients with lymphoproliferation and autoimmune cytopenia

32. 2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborative Initiative

34. Essential medicines for childhood cancer in Europe: a pan-European, systematic analysis by SIOPE

35. Global effort to evacuate Ukrainian children with cancer and blood disorders who have been affected by war

36. Initial presenting manifestations in 16,486 patients with inborn errors of immunity include infections and noninfectious manifestations

37. Development and initial validation of the macrophage activation syndrome/primary hemophagocytic lymphohistiocytosis score, a diagnostic tool that differentiates primary hemophagocytic lymphohistiocytosis from macrophage activation syndrome

38. Diagnostic guidelines for familial hemophagocytic lymphohistiocytosis revisited.

39. Case report: Granulocyte-macrophage colony-stimulating factor sargramostim did not rescue the neutrophil phenotype in two patients with JAGN1-mutant severe congenital neutropenia.

40. Correction: Patients and mice with deficiency in the SNARE protein SYNTAXIN-11 have a secondary B cell defect.

41. Patients and mice with deficiency in the SNARE protein SYNTAXIN-11 have a secondary B cell defect.

42. Inborn errors of immunity with susceptibility to S. aureus infections.

43. Survival in primary hemophagocytic lymphohistiocytosis, 2016 to 2021: etoposide is better than its reputation.

44. Ustekinumab for pyoderma gangrenosum-like skin ulcerations in late-onset leukocyte adhesion deficiency.

45. Diagnostic evaluation of paediatric autoimmune lymphoproliferative immunodeficiencies (ALPID): a prospective cohort study.

46. Abnormal biomarkers predict complex FAS or FADD defects missed by exome sequencing.

47. Hemophagocytic Lymphohistiocytosis in the Context of Hematological Malignancies and Solid Tumors.

48. Prospective Newborn Screening for SCID in Germany: A First Analysis by the Pediatric Immunology Working Group (API).

49. Immunodeficiency with susceptibility to lymphoma with complex genotype affecting energy metabolism ( FBP1, ACAD9) and vesicle trafficking (RAB27A) .

50. MAP kinase activating death domain deficiency is a novel cause of impaired lymphocyte cytotoxicity.

Catalog

Books, media, physical & digital resources